Market Turmoil: Earnings Collapse, Fed Shock, and AI Bloodbath Drive 2026 Crash



Market Turmoil: Earnings Collapse, Fed Shock, and AI Bloodbath Drive 2026 Crash
Market Turmoil: Earnings Collapse, Fed Shock, and AI Bloodbath Drive 2026 Crash
Nasdaq 100 in freefall as earnings collapse and Fed policy shock expose market fragility. Analysis from Schwab Network.

Lead: The Nasdaq 100’s worst week since 2020 reveals a market in freefall.

Between the close of trading on Wall Street and the opening bell in Chicago, the Dow Jones Industrial Average shed 420 points while the Russell 2000 cratered by 7%. The immediate catalyst? A brutal earnings season that wiped out AI sector gains, leaving investors staring at red ink across their portfolios.

Key revelation: The Fed’s latest policy signals have exposed a fundamental mismatch between market expectations and economic reality, escalating the selloff into a full-blown liquidity crisis.

Sam Vardas, Empower Investment Strategist, joins Schwab Network’s panel discussion alongside Mali Caden from Dow Jones and Marta Norton from Nasdaq to dissect what went wrong and what happens next.

Press Monitor Clips: Market Reaction to Earnings and Fed Meeting; Schwab Network Branding and Market Coverage Introduction; Visa Earnings Analysis and Market Strategy Discussion

Industry Solutions
Industry Solutions
Use sector-specific monitoring packages built for regulated industries, public markets, professional services, and complex business environments.
|
Sports Solutions
Sports Solutions
Track leagues, clubs, sponsors, rights holders, and sports-business developments across the global sports ecosystem.
|
Comprehensive AI Monitoring for Firms and Investors
Comprehensive AI Monitoring for Firms and Investors
Join our industry-leading monitoring service for real-time updates across AI firms and investor activities.
|
Oil and Gas Monitoring Service | Real-time Insights
Oil and Gas Monitoring Service | Real-time Insights
Stay informed with our comprehensive oil and gas monitoring service. Track global developments in real-time.
|
Pharmaceuticals and Biotechnology Monitoring Service
Pharmaceuticals and Biotechnology Monitoring Service
Comprehensive monitoring service for the pharmaceutical and biotechnology sectors, delivering real-time insights on drug approvals, pricing, and regulatory developments.
|